This invention provides gene expression profiles useful for diag lacunar stroke and for distinguishing lacunar stroke from non-lacunar stroke.
Methods for the treatment of stroke, such as stroke of undetermined origin, by administration of xenon (Xe)-loaded liposome compositions are provided.
In particular, methods and compositions for the treatment of stroke are disclosed herein.
Apparatus and methods for treatment of stroke are provided.
Disclosed is a therapeutic material for cerebral infarction, which can recover a vascular disorder in an area affected by cerebral infarction to improve the brain function.
The sudden onset of neurological symptoms is an indicator of a possible stroke, also termed a cerebrovascular accident.
The methods of Metabolomic database evaluation have application to stroke.
Elevated levels of unbound free fatty acids from blood are used as indicators of stroke.
Stored data may be adapted to new data, if no stroke was detected.
In particular, pyrrole compounds, compositions and methods for the treatment of stroke are disclosed herein.
By providing neuroprotection,, stroke or ischemic stroke can be prevented and/or treated.
Also disclosed herein are articles of manufacture and kits for the treatment of stroke, e.g., ischemic stroke, e.g., acute ischemic stroke.
The purpose of the present invention is to provide a novel method for determining stroke/cerebral infarction (particularly asymptomatic cerebral infarction), which has no burden on subjects.
The present invention relates to methods for the diagnosis and evaluation of stroke and stroke sub-type.